PhytoHealth Corporation (4108.TW)
TWD 16.15
(0.31%)
TWD 16.15
(0.31%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 17.46 Million TWD | -12.9% |
| 2022 | 20.04 Million TWD | -1.43% |
| 2021 | 20.33 Million TWD | 50.74% |
| 2020 | 13.49 Million TWD | 115.34% |
| 2019 | 6.26 Million TWD | 0.0% |
| 2018 | - TWD | 0.0% |
| 2017 | - TWD | 0.0% |
| 2016 | - TWD | 0.0% |
| 2015 | - TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| 2011 | - TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 16.68 Million TWD | 0.0% |
| 2024 Q2 | 15.03 Million TWD | 0.0% |
| 2023 Q3 | 20.1 Million TWD | 30.19% |
| 2023 Q4 | 17.46 Million TWD | -13.16% |
| 2023 FY | 17.46 Million TWD | -12.9% |
| 2023 Q1 | 17.74 Million TWD | -11.47% |
| 2023 Q2 | 15.44 Million TWD | -12.98% |
| 2022 Q3 | 16.27 Million TWD | -6.87% |
| 2022 Q2 | 17.47 Million TWD | -7.57% |
| 2022 FY | 20.04 Million TWD | -1.43% |
| 2022 Q1 | 18.9 Million TWD | -7.02% |
| 2022 Q4 | 20.04 Million TWD | 23.16% |
| 2021 Q1 | 27.86 Million TWD | 106.51% |
| 2021 Q2 | 25.26 Million TWD | -9.31% |
| 2021 FY | 20.33 Million TWD | 50.74% |
| 2021 Q3 | 22.66 Million TWD | -10.29% |
| 2021 Q4 | 20.33 Million TWD | -10.27% |
| 2020 FY | 13.49 Million TWD | 115.34% |
| 2020 Q3 | 14.18 Million TWD | -17.39% |
| 2020 Q1 | 5.56 Million TWD | -11.14% |
| 2020 Q2 | 17.16 Million TWD | 208.41% |
| 2020 Q4 | 13.49 Million TWD | -4.88% |
| 2019 Q1 | 13.05 Million TWD | 0.0% |
| 2019 Q3 | 8.53 Million TWD | -20.96% |
| 2019 Q4 | 6.26 Million TWD | -26.6% |
| 2019 FY | 6.26 Million TWD | 0.0% |
| 2019 Q2 | 10.79 Million TWD | -17.31% |
| 2018 Q2 | - TWD | 0.0% |
| 2018 Q3 | - TWD | 0.0% |
| 2018 Q4 | - TWD | 0.0% |
| 2018 Q1 | - TWD | 0.0% |
| 2018 FY | - TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2017 FY | - TWD | 0.0% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 Q3 | - TWD | 0.0% |
| 2017 Q2 | - TWD | 0.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2016 Q1 | - TWD | 0.0% |
| 2016 FY | - TWD | 0.0% |
| 2016 Q3 | - TWD | 0.0% |
| 2016 Q4 | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 FY | - TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q3 | - TWD | 0.0% |
| 2013 Q2 | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| 2012 Q1 | - TWD | 0.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2012 Q3 | - TWD | 0.0% |
| 2011 Q2 | - TWD | 0.0% |
| 2011 Q1 | - TWD | 0.0% |
| 2011 Q3 | - TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Grape King Bio Ltd | 136.36 Million TWD | 87.196% |
| Standard Chem & Pharm CO., LTD. | 222.97 Million TWD | 92.169% |
| Maywufa Company Ltd. | 438.97 Million TWD | 96.023% |
| ScinoPharm Taiwan, Ltd. | 570.23 Million TWD | 96.938% |
| Lotus Pharmaceutical Co., Ltd. | 9.51 Billion TWD | 99.817% |
| LIWANLI Innovation Co., Ltd. | 361 Thousand TWD | -4736.565% |
| YungShin Global Holding Corporation | 241.99 Million TWD | 92.785% |
| SCI Pharmtech, Inc. | 845.52 Million TWD | 97.935% |
| Formosa Laboratories, Inc. | 2.03 Billion TWD | 99.143% |
| PharmaEssentia Corporation | 954.99 Million TWD | 98.172% |
| Bora Pharmaceuticals Co., LTD. | 3.48 Billion TWD | 99.499% |